HCV E2 Protein and Interferon Resistance
Author Information
Author(s): Afzal Samia, Idrees Muhammad, Ali Muhammad, Ilyas Muhammad, Hussain Abrar, Akram Madiha, Butt Sadia, Saleem Sana, Rehman Irshad ur, Ali Liaqat, Shahid Muhammad
Primary Institution: National Centre of Excellence in Molecular Biology, University of the Punjab, Lahore, Pakistan
Hypothesis
The phosphorylation of serine residues in the E2 protein of hepatitis C virus (HCV) plays a significant role in the virus's resistance to interferon treatment.
Conclusion
The study identifies serine 75 and 277 of the HCV E2 gene as key phosphorylation sites that contribute to interferon resistance.
Supporting Evidence
- HCV E2 protein inhibits the kinase activity of PKR, which is crucial for the antiviral response.
- The study identified two phosphorylation sites on the E2 protein that interact with specific kinases.
- The findings suggest that these phosphorylation sites may be targeted for developing new treatments against HCV.
Takeaway
The hepatitis C virus has a part that helps it avoid being attacked by medicine, and scientists found two important spots on that part that might help it do that.
Methodology
The study used a combination of in-silico analysis and laboratory experiments to identify phosphorylation sites on the E2 protein of HCV.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website